当代PCI患者中ARC高出血风险定义的验证
该研究在2014至2017年单中心接受冠脉支架植入的9623例患者中验证ARC-HBR定义,44.4%符合HBR。HBR患者1年主要出血终点发生率为9.1%,显著高于非HBR的3.2%(p<0.001),且出血风险随满足ARC-HBR定义次数呈阶梯式增加。
要点
- ARC-HBR定义可有效识别PCI术后高出血风险患者,44.4%的患者符合HBR标准。
- HBR患者1年出血事件(9.1% vs 3.2%,p<0.001)及血栓事件、全因死亡均显著增高。
- 满足ARC-HBR定义次数越多,出血风险呈阶梯式递增,提示多重标准共存有附加预后价值。
核心结论
- ARC-HBR定义在当代PCI患者中具有验证价值,可识别出血及血栓事件(含全因死亡)风险增高的患者。
- 多重ARC-HBR标准共存显示附加预后价值。
研究设计与样本
- 单中心回顾性队列研究,纳入2014至2017年接受冠状动脉支架植入的患者9623例。
- HBR定义为满足至少1项主要或2项次要ARC-HBR标准,并按满足定义次数进一步分层。
- 主要终点为围术期住院或出院后1年出血的复合终点。
主要发现
- 9623例患者中4278例(44.4%)符合HBR标准。
- 中度或重度贫血是最常见的主要标准(33.2%);年龄≥75岁是最常见的次要标准及总体最常见标准(46.8%)。
- HBR患者1年主要出血终点发生率为9.1%,非HBR患者为3.2%(p<0.001)。
- 出血风险随满足ARC-HBR定义次数呈阶梯式增加。
- HBR患者所有次要终点(主要出血终点各组分、心肌梗死、全因死亡)发生率均显著更高。
关键数值与推荐
- HBR定义:满足至少1项主要或2项次要ARC-HBR标准。
- 主要出血终点:围术期住院或出院后1年出血的复合终点。
- HBR患者1年主要出血终点9.1% vs 非HBR 3.2%(p<0.001)。
临床怎么用
- 可采用ARC-HBR定义对PCI患者进行出血风险分层,识别高出血风险人群。
- 对符合多重ARC-HBR标准的患者应加强出血风险评估与监测。
- HBR患者血栓事件及全因死亡风险亦增高,临床管理需平衡出血与缺血风险。
局限性
- 单中心真实世界队列研究,结果外推需谨慎。
- 原文未报告研究的具体局限性描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bleeding following percutaneous coronary intervention has important prognostic implications. The Academic Research Consortium (ARC) recently proposed a list of clinical criteria to define patients at high bleeding risk (HBR). OBJECTIVES: This study sought to validate the ARC definition for HBR patients in a contemporary real-world cohort. METHODS: Patients undergoing coronary stenting between 2014 and 2017 at a tertiary-care center were defined as HBR if they met at least 1 major or 2 minor ARC-HBR criteria. To account for the presence of multiple criteria, patients were further stratified by the number of times they fulfilled the ARC-HBR definition. The primary endpoint was a composite of peri-procedural in-hospital or post-discharge bleeding at 1 year. Secondary endpoints included individual components of the primary bleeding endpoint, myocardial infarction, and all-cause mortality. RESULTS: Among 9,623 patients, 4,278 (44.4%) qualified as HBR. Moderate or severe anemia was the most common major criterion (33.2%); age ≥75 years was the most frequent minor criterion and the most common overall (46.8%). The rate of the primary bleeding endpoint at 1 year was 9.1% in HBR patients compared with 3.2% in non-HBR patients (p < 0.001), with a stepwise increase in bleeding risk corresponding to the number of times the ARC-HBR definition was fulfilled. HBR patients also experienced significantly higher rates of all secondary endpoints. CONCLUSIONS: This study validates the ARC-HBR definition in a contemporary group of patients who underwent percutaneous coronary intervention. The ARC-HBR definition identified patients at increased risk not only for bleeding but also for thrombotic events, including all-cause mortality. Coexistence of multiple ARC-HBR criteria showed additive prognostic value.
引用
- Cao D, Mehran R, Dangas G, et al. Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients. J Am Coll Cardiol. 2020. PMID: 32466887. doi:10.1016/j.jacc.2020.03.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。